Siri Lillegraven, MD, PhD, MPH

Diakonhjemmet Hospital
Oslo, Norway

Dr. Lillegraven (MD MPH PhD) is the vice director for the REMEDY Center for treatment of Rheumatic and Musculoskeletal Diseases, and the leader for the Unit for Clinical Research at Diakonhjemmet Hospital, Oslo, Norway

Presentation(s):

• Effect of Tapered Versus Stable Treatment with Tumor Necrosis Factor Inhibitors on Disease Flares in Patients with Rheumatoid Arthritis in Remission: A Randomized, Open-Label, Non-Inferiority Trial

  Tuesday, November 14, 2023
  7:50 AM – 8:00 AM PT

  Disclosure(s): Boehringer-Ingelheim: Grant/Research Support (Ongoing)

• 2126: Performance of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Relation to Flares in Disease Activity

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): Boehringer-Ingelheim: Grant/Research Support (Ongoing)

• L07: 3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Rheumatoid Arthritis Patients in Sustained Remission: A Multicenter Randomized Trial

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2543: Clinical and Radiographic Results of Tapering and Withdrawing CsDMARDs versus Stable Treatment in Patients with Rheumatoid Arthritis in Remission: 3-year Results from a Randomized Controlled Trial

  Tuesday, November 14, 2023
  5:00 PM – 5:10 PM PT

  Disclosure(s): Boehringer-Ingelheim: Grant/Research Support (Ongoing)